Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -399.20K | -398.30K | -328.00K | -328.30K | -148.10K |
| Total Depreciation and Amortization | 244.90K | 244.30K | 79.20K | 79.20K | 44.20K |
| Total Amortization of Deferred Charges | -- | -- | 146.00K | 146.10K | -- |
| Total Other Non-Cash Items | 463.60K | 462.50K | -1.09M | -1.09M | -78.70K |
| Change in Net Operating Assets | -847.30K | -845.30K | 799.50K | 800.20K | 158.70K |
| Cash from Operations | -538.00K | -536.70K | -388.80K | -389.10K | -24.00K |
| Capital Expenditure | -24.30K | -24.20K | -11.40K | -11.50K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 230.00K | 230.20K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.00K | 39.00K | 40.50K | 40.50K | 44.10K |
| Cash from Investing | 14.70K | 14.70K | 259.10K | 259.30K | 44.10K |
| Total Debt Issued | 2.77M | 2.77M | 608.50K | 608.50K | 500.00K |
| Total Debt Repaid | -265.00K | -265.00K | -265.00K | -265.00K | -307.00K |
| Issuance of Common Stock | 6.67M | 6.67M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -172.00K | -172.00K | -119.50K | -119.50K | -7.50K |
| Cash from Financing | 1.15M | 1.15M | 28.60K | 28.70K | 23.70K |
| Foreign Exchange rate Adjustments | -214.90K | -214.40K | -112.90K | -113.00K | -45.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 415.80K | 414.80K | -214.00K | -214.20K | -1.90K |